A North-West London Experience of the Impact of Treatment Related Toxicity on Clinical Outcomes of Elderly Patients with Germ Cell Tumors.
Date
2022-10-11ICR Author
Author
Sharma, A
Morrison, L
Milic, M
Ghose, A
Gogbashian, A
Vasdev, N
Agarwal, S
Pullar, B
Rustin, G
Type
Journal Article
Metadata
Show full item recordAbstract
BACKGROUND/AIM: The occurrence of germ cell tumour (GCT) in the elderly is rare, with scarce data available. The aim of this study was to understand the clinical outcomes of patients with GCT in patients aged > 45 years. MATERIALS AND METHODS: A retrospective study was conducted in a large tertiary cancer centre in north-west London. Between 1 January 2003 and 31 March 2022, 108 cases of GCT in men aged > 45 years were identified and treated at the Mount Vernon Cancer Centre. The median age at diagnosis was 54 years (range = 45-70 years). RESULTS: The 5-year survival rate of all patients was 96%, and the toxicity profile was similar to the younger age group. CONCLUSION: Older patients with GCT are able to tolerate chemotherapy; however, care must be taken to prevent life-threatening complications using appropriate dose modification.
Collections
Subject
chemotherapy
clinical outcomes
complications
elderly
testicular cancer
Language
eng
Date accepted
2022-10-09
License start date
2022-10-11
Citation
Cancers, 2022, 14 (20), pp. 4977 -
Publisher
MDPI